Evidence map›Paper›PMID 35954197›Full record

ArticleCells2022

Mutated

Nadia Bertola, Paolo Degan, Enrico Cappelli, Silvia Ravera

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Nadia BertolaDepartment of Experimental Medicine, University of Genoa, Via De Toni 14, 16132 Genova, Italy.ORCID 0000-0003-4591-3260
Paolo DeganU.O. Mutagenesi IRCCS Policlinico San Martino-IST (Istituto Nazionale per la Ricerca sul Cancro), Largo Rosanna Benzi 10, 16132 Genova, Italy.
Enrico CappelliHaematology Unit, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini 5, 16148 Genova, Italy.
Silvia RaveraDepartment of Experimental Medicine, University of Genoa, Via De Toni 14, 16132 Genova, Italy.ORCID 0000-0002-0803-1042
University of Genoa · ITIstituto Giannina Gaslini · ITOspedale Policlinico San Martino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fanconi Anaemia (FA) is a rare recessive genetic disorder characterized by a defective DNA repair mechanism. Although aplastic anaemia is the principal clinical sign in FA, patients develop a head and neck squamous cell carcinoma (HNSCC) with a frequency 500-700 folds higher than the general population, which appears more aggressive, with survival of under two years. Since FA gene mutations are also associated with a defect in the aerobic metabolism and an increased oxidative stress accumulation, this work aims to evaluate the effect of

Indexed as

Fanconi AnemiaHead and Neck NeoplasmsFanconi Anemia Complementation Group A ProteinGlycolysisHumansMitochondrial DynamicsSquamous Cell Carcinoma of Head and NeckFANCA protein, humanFanconi Anemia Complementation Group A Proteinanaerobic glycolysisantioxidant defencesautophagydouble-strand DNA damageFanconi AnaemiaHNSCCmitochondrial fusion and fissionmitophagyoxidative phosphorylationoxidative stress

Identifiers

PMID35954197
PMCPMC9425438
OpenAlexW4289109872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.